DavidBCliffordMD

PubMed

• 8 citations
  Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
  Olivia Wagemann, Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner
  JAMA Neurology. 2024-06-01
• 1 citations
  Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
  Guoqiao Wang, Yan Li, Chengjie Xiong, Tammie L S Benzinger, Brian A Gordon
  Alzheimer's & Dementia. 2024-04-01
• Mycobacterium haemophilum Related Myelitis in Geographically Linked Cases.
  Rohini D Samudralwar, Thomas C Bailey, Ananth K Vellimana, Neill M Wright, David B Clifford
  Annals of Neurology. 2024-03-01

Journal Articles

• Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome  
  Giacomini PS, Rosenberg A, Metz I, Araujo D, Arbour N, Bar-Or A for the Maraviroc in Multiple Sclerosis-Associated PML-IRIS (MIMSAPI) Group, N Engl J Med, 1/1/2014
• Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder  
  Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA, Clinical Infectious Diseases, 1/1/2014
• Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV antiretroviral therapy effects resear...  
  Biswas B, Spitznagel E, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB, the CHARTER Group, Journal of HIV/AIDS & Social Services, 1/1/2014
• Neuroinfectious disease: A rapidly evolving challenge  
  Clifford DB, Neurol Clin Pract, 1/1/2014
• The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV  
  Hammond ER, Crum RM, Treisman GJ, Mehta SH, Marra CM, Clifford DB, Morgello S, Simpson DM, Gelman BB, Ellis RJ, Grant I, Letendre SL, McArthur JC for the CHARTER Group, Am J Epidemiol, 1/1/2014
• The relationship of CPE to HIV dementia Slain by an ugly fact?  
  Berger JR, Clifford DB, Neurology, 1/1/2014
• Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals  
  Kalayjian RC, Wu K, Evans S, Clifford DB, Pallaki M, Currier JS, Smryzynski M, J Acquir Immune Defic Syndr, 1/1/2014
• The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons  
  Overton ET, Azad TD, Parker N, Demarco Shaw D, Frain J, Spitz T, Westerhaus E, Paul R, Clifford DB, Ances BA, J. Neurovirol, 1/1/2013
• Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort  
  Sakamoto M, Marcotte TD, Umlauf A, Franklin D Jr, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, Woods SP, Collier AC, Marra CM, Clifford DB, G..., JAIDS, 1/1/2013
• PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section  
  Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, Bartt R, Major EO, Nath A, Neurology, 1/1/2013
• Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND  
  Chalermchai T, Valcour V, Sithinamsuwan P, Pinyakorn S, Clifford D, Paul RH, Tipsuk S, Fletcher JLK, DeGruttola V, Ratto-Kim S, Hutchings N, Shikuma C, Ananworanich J,..., J Neurovirol, 1/1/2013
• Natalizumab Bench to bedside and beyond  
  Rudick R, Polman C, Clifford D, Miller D, Steinman L, JAMA Neurol, 1/1/2013
• A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes  
  Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, Zhao Z, Duda P, J Neurovirol, 1/1/2013
• Susac syndrome in a patient with human immunodeficiency virus infection  
  Longbrake EE, Ances BM, Viets RB, Clifford DB, J Neurovirol, 1/1/2013
• Tumefactive demyelination in a patient with human immunodeficiency virus  
  Solomon IH, Perrin RJ, Clifford DB, Ances BM, J Neurovirol, 1/1/2013
• HIV DNA reservoir increases risk for cognitive disorders in cART-Naive patients  
  Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A, Shikuma C, Liang C, Jirajariyavej S, Sithinamsuwan P, Tipsuk S, Clifford DB, Paul R, Flet..., PLOS ONE, 1/1/2013
• Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection  
  Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre SL, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau DJ, Wolfson T, Heaton RK, Gamst AC, F..., J NeuroVirol, 1/1/2013
• CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, Part 1: Overview and discussion of progressive multifocal leukoencephalopathy-immune r...  
  Post MJD, Thurnher MM, Clifford DB, Nath A, Gonzalez RG, Gupta RK, Post KK, Am J Neuroradiol, 1/1/2013
• CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, Part 2: Discussion of neuro-immune reconstitution inflammatory syndrome with and witho...  
  Post MJD, Thurnher MM, Clifford DB, Nath A, Gonzalez RG, Gupta RK, Post KK, Am J Neuroradiol, 1/1/2013
• Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial  
  Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, F..., Revue Neurologique, 1/1/2013
• Peripheral neuropathy in ART-experienced patients: prevalence and risk factors  
  Chen H, Clifford DB, Deng L, Wu K, Lee AJ, Bosch RJ, Riddler SA, Ellis RJ, Evans SR, J Neurovirol, 1/1/2013
• MRI pre-clinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy  
  Phan-Ba R, Lommers E, Tshibanda L, Calay P, Dubois B, Moonen G, Clifford D, Belachew S, J Neurol. Neurosurg. Psychiatry, 1/1/2012
• 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder  
  Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DB, Morris JC, Clifford DB, Arch. Neurol., 1/1/2012
• Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS  
  Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H, Levy RH, Neurology, 1/1/2012
• A randomized, double-blind, controlled study of NGX-4010, a Capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy  
  Clifford DB, Simpson DM, Brown S, Moyle G, Brew BJ, Conway B, Tobias JK, Vanhove GF, for the NGX-4010 C119 Study Group, J. Acquir. Immune Defic. Syndr., 1/1/2012
• Join now to see all

Books/Book Chapters

• Global HIV/AIDS Medicine 
  Chapter: Primary neurological manifestation of HIV/AIDS. 
  Page 261 - 269Clifford DB, Mitike MTEditors: Volberding PA, Sande MA, Lange J, Greene WC.Saunders Elsevier2008
• Handbook of Dementing Illnesses 
  Chapter: HIV-associated dementia. 
  Page 321 - 331Clifford DB, Gould MEditors: Morris JC, Galvin JE, Holtzman DM.Taylor and Francis Group, New York, NYEdition 2nd,2006
• Neurological Therapeutics Principles and Practice 
  Chapter: Neurological complications of HIV infection. 
  Page 1060 - 1073Clifford DBEditors: Biller J, Cairncross JG, Dyck PJ, Edmeads JG, Engel AG, Fahn S, Ford B, Gilliam FG, Heilman KM, Noseworthy JH, Patterson MC, Roos KL, Samuels MA, Sharpe JA, Wijdicks EFM.Informa Healthcare, LondonEdition 2nd,2006
• The Neurology of AIDS 
  Chapter: Treatment of opportunistic infections associated with HIV infection. 
  Page 721 - 727Clifford DBEditors: Gendelman HE, Grant I, Everall IP, Lipton SA, Swindells S.Oxford University Press, New York, NYEdition 2nd,2005
• Current Therapy in Neurologic Disease 
  Chapter: Neurologic diseases associated with HIV-1 infection. 
  Page 130 - 134Clifford DBEditors: Johnson RT, Griffin JW, McArthur JC.Mosby, St. Louis, MOEdition 6th,2002
• Oxford Textbook of Critical Care 
  Chapter: Encephalitis. 
  Paczinski R and Clifford DBEditors: Webb,A.R., Shapiro, M.J., Singer, M., Suter, P.M..Oxford University Press1999
• The Neurology of AIDS 
  Chapter: Antiviral therapies for HIV infection and implications for treatment of neurological manifestations An Overview. 
  Page 353 - 363Clifford DBEditors: HE Gendelman, Stuart Lipton, Leon Epstein, and Susan Swindells.Chapman & Hall1997
• Handbook of Dementing Illnesses 
  Chapter: AIDS Dementia. 
  Clifford DB and Glicksman MEditors: J. Morris.Marcel Dekkar, New York1994
• Biotechnology of CNS HIV 
  Chapter: The ACTG in the 1990's. 
  Clifford DB1993
• Neurological Pathophysiology 
  Chapter: Somatosensory system: Pain. 
  Page 75 - 85Clifford DBEditors: Collins RC, Pearlman A.Oxford University Press, New York1984
• Manual of HIV Therapeutics 
  Chapter: Neurologic and Psychiatric Complications 
  Page 101 - 111Clifford DBEditors: W. Powderly.Lippincott-Raven, Philadelphia
• Join now to see all

Abstracts/Posters

• MBL2 promoter polymorphism rs7096206 predicts brain metabolite anomalies in HIV-infected adults.
  Singh KK, Deng Q, Fennema-Notestine C, Vaida F, Ellis RJ, Letendre S, Franklin D, Rosario D, Corkran S, Gelman BB, Clifford DB, Collier AC, Marra CM, McArthur JC, Morg..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.
  Wagner GA, Franklin DR, Caballero G, Chaillon A, Kosakovsky Pond SL, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Gelman BB, Collier AC, Marra CM, Clifford DB, H..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• CSF biomarker profile in HIV patients with and without CSF viral escape.
  Perez-Valero I, Letendre S, Heaton R, Ellis R, McCutchan A, Simpson D, Deutsch R, Grant I and the CHARTER Group, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• HIV-replication control rates needed to prevent Neurocognitive Performance (NP) decline.
  Perez-Valero I, Heaton R, Franklin D, Letendre S, Deutsch R, Gelman B, Simpson D, Collier A, Grant I and the CHARTER Group, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• Blood cell indices and neurocognitive impairment in the HAART Era: A CHARTER Study.
  Kallianpur A, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre S, Ellis R, Heaton R, Franklin D, Barnholtz-Sloan J, Collier A, Marra C, Clifford D, Gelman B, McArthur J, Morg..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• Mitochondrial DNA haplogrouops and neurocognitive impairment in the CHARTER Cohort.
  Hulgan T, Samuels DC, Bush W, Ellis R, Letendre S, Franklin D, Heaton R, Gelman BB, Clifford DB, Collier AC, Marra CM, McArthur JC, Morgello S, Simpson DM, McCutchan J..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• Abdominal obesity, inflammation, immune activation and neurocognitive impairment.
  Sattler F, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Collier A, Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, Grant I, ..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• HLA gene loci associated with HIV load in CSF and blood plasma in the CHARTER Cohort.
  Gelman BB, Ahuja SK, Ellis RJ, Letendre S, Marra CM, McArthur J, Morgello S, Clifford DB, Grant I, Vaida F for the CHARTER Group, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• CSF biomarkers correlate with magnetic resonance spectroscopy metabolites during HIV disease.
  Anderson AM, Fennema-Notestine C, Umlauf A, Clifford D, Marra C, Collier A, Gelman B, McArthur J, McCutchan A, Simpson D, Morgello S, Grant I, Letendre S for the CHART..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• The cerebrospinal fluid HIV risk score for assessing central nervous system HIV activity.
  Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, McArthur JC, for the CHARTER Group, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• CNS immunoactivation in HIV-patients on ART with HIV-associated mild neurocognitive impairment.
  Eden A, Franklin D, Fuchs D, Grant I, Letendre S, Marcotte T, Nisson S, Price RW, Zetterberg H, Gisslen M, for the CHARTER Group, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• Maraviroc for treatment of immune reconstitution inflammatory syndrome following natalizumab-associated progressive multifocal leukoencephalopathy.
  Giacomini PS, Rosenberg A, Araujo D, Boivin MN, Poliquin-Lasnier L, Xia C, Tampieri D, Narayanan S, Arnold DL, Arbour N, Clifford DB, Bar-Or A, 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Lyon, France, 1/1/2012
• Minocycline treatment for HIV-associated cognitive impairment in Uganda.
  Sacktor N, Nakasujja N, Miyahara S, Lee A, Evans S, Robertson K, Katabira E, Musisi S, Clifford D, Neurology, 63rd AAN Meeting, Honolulu, HI, 4/9/2011
• Mefloquine treatment in patients with progressive multifocal leukoencephalopathy (PML).
  Clifford D, Nath A, Cinque P, Brew BJ, Workman A, Giorelik L, Zhao J, Duda P, Neurology, 63rd AAN Meeting, Honolulu, HI, 4/9/2011
• Peripheral neuropathy in HIV-infected patients on an initial ART regimen: Prevalence, prognostic factors, recovery after withdrawal of neurotoxic antiretrovirals, and ...
  Evans SR, Ellis R, Chen H, Lee A, Schifitto G, Wu K, Bosch R, Yeh T, McArthur J, Simpson D, Clifford D, Neurology, 63rd AAN Meeting, Honolulu, HI, 4/9/2011
• Neurocognitive impairment in HIV-infected patients with past syphilis.
  Marra C, Deutsch R, Collier A, Morgello S, Letendre S, Clifford D, Gelman B, McArthur J, McCutchan A, Grant I, CHARTER Group, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Novel screening tools for HIV-associated neurocognitive disorders.
  Overton E, Ances B, Grubb J, Parker N, Spitz T, Frain J, DeMarco-Shaw D, Clifford D, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Lower CSAR are associated with global neurocognitive impairment in antiretroviral-treated people with HIV.
  Letendre S, Croteau D, Ellis R, Clifford D, Gelman B, Marra C, McArthur J, McCutchan A, Simpson D, Grant I, CHARTER Group, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Impact of genetic variation in iron transport pathways on neuropathy morbidity during ART: results from the CHARTER genome-wide study.
  Kallianpur A, Ellis R, Marra C, Simpson D, McArthur J, Clifford D, Gelman B, McCutchan A, Letendre S, Grant I, CHARTER Group, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Minocycline treatment for HAND: results from a multicenter trial.
  Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen B, Paul R, Robertson K, Coombs R, Clifford D, Adult ACTG, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Prolonged HAART causes caudate volume reduction.
  Ortega M, Lee T, Thomas J, Ho P, Clifford D, Vaida F, Ances B, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Amyloid deposition is not increased in HIV+ patients using 11C-PiB.
  Thomas J, Christensen J, Venkat R, Ortega M, Teshome M, Aldea P, Morris J, Clifford D, Benzinger T, Ances B, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Full sequence mtDNA variation and HIV-SN in the CHARTER cohort.
  Holzinger E, Hulgan T, Ellis R, Samuels D, Clifford D, Collier A, Gelman B, Morgello S, Letendre S, Grant I, CHARTER Group, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Therapeutic DRV and ETR concentrations in CSF.
  Best B, Letendre S, Croteau D, Capparelli E, Clifford D, Gelman B, Marra C, McArthur J, Simpson D, Grant I, CHARTER Group, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Combined role of CD4+ and CD8+ T cell responses against JCV in the clinical outcome of patients with PML and PML-IRIS.
  Gheuens S, Bord E, Kesari S, Simpson D, Gandhi R, Clifford D, Berger J, Koralnik I, 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/27/2011
• Join now to see all

Other

• Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. 
  Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A, Katabira E, Clifford DB, Sacktor N, BMC Psychiatry
  1/1/2010
• Targeting HIV therapy for the brain. 
  Clifford DB and Simpson D, HIV:Advances in Research and Therapy
  1/1/1998
• Primary neurologic complications of HIV infection. Improving the Management of HIV disease. 
  Clifford DB
  1/1/1997